Oral contraceptives: their side effects and ophthalmological manifestations.
D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001779:Blood Coagulation Factors; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D003261:Contact Lenses; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000494:pharmacology; D004487:Edema; D004967:Estrogens / Q000009:adverse effects; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced; D005132:Eye Manifestations; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007908:Lens, Crystalline / Q000187:drug effects; D008875:Middle Aged; D009461:Neurologic Manifestations; D009902:Optic Neuritis / Q000139:chemically induced; D011372:Progestins / Q000009:adverse effects; D012171:Retinal Vessels / Q000187:drug effects; D013923:Thromboembolism / Q000139:chemically induced / Q000453:epidemiology
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins